Showing results (1-10 of 6,218) with videos related to
Sort By:
Pageof 622
European Journal of Cancer (Oxford, England : 1990)|July 25, 2013
Low-dose metronomic chemotherapy: a systematic literature analysisK Lien, S Georgsdottir, L Sivanathan, et al.Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|March 1, 1993
Interleukin-1 and experimental gastric ulcer healing in the ratC C Schuerer-Maly, U Emmenegger, K Ott, et al.The Journal of Cell Biology|February 24, 1997
Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumorsC Sers, U Emmenegger, K Husmann, et al.American Journal of Hematology|May 18, 2000
Elevation of soluble Fas and soluble Fas ligand in reactive macrophage activation syndromesU Emmenegger, R Zehnder, U Frey, et al.Digestion|January 1, 1991
Inflammation, capillary leakage and healing of experimental gastric ulcers in the ratC C Schuerer-Maly, K Ott, U Emmenegger, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Cyclophosphamide-methotrexate 'metronomic' chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluationG Bocci, M Tuccori, U Emmenegger, et al.Current Oncology (Toronto, Ont.)|February 28, 2013
When the tumour is not the culprit: avascular necrosis of the hip in a patient with castration-resistant prostate cancerE Chan, G Chan, L Ehrlich, et al.Acta Neurologica Scandinavica|September 1, 1987
Selegiline (1-deprenyl) and low-dose levodopa treatment of Parkinson's disease. A double-blind crossover trialJ Presthus, J Berstad, K LienAmerican Journal of Hematology|September 18, 2001
Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromesU Emmenegger, U Frey, A Reimers, et al.Pageof 622